Pharco Launches Major Glaucoma Awareness Campaign

Pharco Pharmaceuticals, one of the largest pharmaceutical companies in Egypt and the Middle East, has launched a nation-wide campaign to raise awareness on various glaucoma conditions and the need for eye pressure examinations to negate its drastic effects. The campaign is a testament to Pharco’s continuous efforts to raise awareness of the common high-risk diseases such as glaucoma with the participation of several ophthalmologists. The initiative offers free medical consultations through Pharco’s company hotline.

 

Glaucoma is a common eye condition where the optic nerve, which connects the eye to the brain, becomes damaged. It is usually caused by fluid building up in the front part of the eye, which increases pressure inside the eye. Glaucoma can lead to loss of vision or partial blindness if it is not diagnosed and treated early. Studies on the condition indicate that the number of patients has grown from 60.5 million people in 2010 to 79.6 million people in 2020, despite ongoing medical progress in treating the condition, which necessitates early detection of patients.

 

Pharco’s campaign comes in support of the Ministry of Health's efforts to raise awareness on several chronic and severe diseases affecting society. The campaign also marks World Glaucoma Week celebrated every year in March to shed light and curb the spread of the condition. 

 

In this context, Dr. Mohamed Sherine, CEO of the Scientific Offices at Pharco Pharmaceuticals, explained that the core of the campaign focuses on spreading awareness on Glaucoma and providing medical services to people with the condition, in line with the state's efforts to combat vision loss. “Our goal is to create an informative database for glaucoma patients that provides the latest treatment methods to help patients across Egypt to aid in early detection and possible negation of its side effects,” he explained. 

 

Glaucoma is one of the most common causes of blindness across the world. It is an asymptomatic disease which leads to higher stakes of high-risk complications. Early diagnosis of glaucoma can only be done through examination of the eye and measuring eye pressure; this is where the importance of Pharco’s campaign lies; to raise awareness on the disease.  

 

Over the past couple of years, Pharco Pharmaceuticals launched several awareness campaigns on severe diseases such as its major campaign to raise awareness on diabetes and its complications. In addition, Pharco was proudly a key partner of the hepatitis C campaign that succeeded in announcing Egypt as a hepatitis-free country last year.